Literature DB >> 19497054

A simple two-step culture system for the large-scale generation of mature and functional dendritic cells from umbilical cord blood CD34+ cells.

Sreekumar Balan1, Vaijayanti P Kale, Lalita S Limaye.   

Abstract

BACKGROUND: In vitro generated dendritic cells (DCs) are widely used as adjuvants in cancer immunotherapy. The major sources for DC generation are monocytes and CD34+ cells. CD34+-derived DCs are less frequently used in clinical applications because it requires complex generation methods. Here a simple method for the large-scale generation of mature functional DCs from umbilical cord blood-derived CD34+ cells is described. STUDY DESIGN AND METHODS: CD34+ cells were first expanded with a combination of early acting growth factors in a medium containing autologous plasma. In the second step the DC precursors were further either enriched by plastic adherence or sorted on a cell sorter and differentiated as DCs. DCs generated by both methods were compared for their morphology, phenotype, and different functional variables.
RESULTS: This culture system provided a large-scale expansion of CD34+ cells giving a mean fold increase of 615. The majority of the expanded cells were interstitial DC precursors, that is, CD14+-positive cells. In vitro generated immature DCs could be matured into functional DCs by appropriate maturation stimuli. DCs generated by the plastic adherence method had a better cytokine profile and strong mixed leukocyte reaction compared to those generated by cell sorting.
CONCLUSION: A two-step culture system provides a large-scale expansion of CD34+ cells with a preferential lineage commitment toward CD14+ cells. Enrichment of these precursors with a simple plastic adherence technique results in generation of large numbers of mature, functional DCs. This method of in vitro DC generation will have applications in cancer immunotherapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19497054     DOI: 10.1111/j.1537-2995.2009.02231.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  8 in total

Review 1.  Umbilical cord blood immunology: relevance to stem cell transplantation.

Authors:  Syh-Jae Lin; Dah-Chin Yan; Yen-Chang Lee; Hsiu-Shan Hsiao; Pei-Tzu Lee; Yu-Wen Liang; Ming-Ling Kuo
Journal:  Clin Rev Allergy Immunol       Date:  2012-02       Impact factor: 8.667

2.  Generation of a cord blood-derived Wilms Tumor 1 dendritic cell vaccine for AML patients treated with allogeneic cord blood transplantation.

Authors:  Colin de Haar; Maud Plantinga; Nina Jg Blokland; Niek P van Til; Thijs Wh Flinsenberg; Viggo F Van Tendeloo; Evelien L Smits; Louis Boon; Lotte Spel; Marianne Boes; Jaap Jan Boelens; Stefan Nierkens
Journal:  Oncoimmunology       Date:  2015-05-27       Impact factor: 8.110

3.  Antimicrobial peptide LL-37 along with peptidoglycan drive monocyte polarization toward CD14(high)CD16(+) subset and may play a crucial role in the pathogenesis of psoriasis guttata.

Authors:  Lei Qian; Wei Chen; Wen Sun; Ming Li; Renshan Zheng; Qing Qian; Lianzheng Lv
Journal:  Am J Transl Res       Date:  2015-06-15       Impact factor: 4.060

4.  Cytokine-based high log-scale expansion of functional human dendritic cells from cord-blood CD34-positive cells.

Authors:  Yui Harada; Yae Okada-Nakanishi; Yasuji Ueda; Shunichi Tsujitani; Satoru Saito; Terumi Fuji-Ogawa; Akihiro Iida; Mamoru Hasegawa; Tomohiko Ichikawa; Yoshikazu Yonemitsu
Journal:  Sci Rep       Date:  2011-11-29       Impact factor: 4.379

5.  Exogenous addition of arachidonic acid to the culture media enhances the functionality of dendritic cells for their possible use in cancer immunotherapy.

Authors:  Jeetendra Kumar; Rupali Gurav; Vaijayanti Kale; Lalita Limaye
Journal:  PLoS One       Date:  2014-11-04       Impact factor: 3.240

Review 6.  COVID-19 immunotherapy: Treatment based on the immune cell-mediated approaches.

Authors:  Mahdi Zavvar; Aisan Yahyapoor; Hamed Baghdadi; Sina Zargaran; Sara Assadiasl; Kamal Abdolmohammadi; Amir Hossein Abooei; Mohammad Reza Sattarian; Melina JalaliFarahani; Negar Zarei; Amirali Farahvash; Yousef Fatahi; Gunnur Deniz; Mitra Zarebavani; Mohammad Hossein Nicknam
Journal:  Int Immunopharmacol       Date:  2022-02-25       Impact factor: 5.714

7.  Umbilical cord blood-derived CD11c(+) dendritic cells could serve as an alternative allogeneic source of dendritic cells for cancer immunotherapy.

Authors:  Jeetendra Kumar; Vaijayanti Kale; Lalita Limaye
Journal:  Stem Cell Res Ther       Date:  2015-09-25       Impact factor: 6.832

8.  A method for the generation of large numbers of dendritic cells from CD34+ hematopoietic stem cells from cord blood.

Authors:  Nicole Bedke; Emily J Swindle; Camelia Molnar; Patrick G Holt; Deborah H Strickland; Graham C Roberts; Ruth Morris; Stephen T Holgate; Donna E Davies; Cornelia Blume
Journal:  J Immunol Methods       Date:  2019-11-09       Impact factor: 2.303

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.